4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| VIE | Ann: Removal from Official List | 23/04/18 | 0 | 50 | |||
|
|||||||
| VIE | Ann: Removal from Official List | 20/04/18 | 0 | 56 | |||
|
|||||||
See All Discussions
ASX News